Who owns Xenon Pharmaceuticals Inc (XENE)? Superinvestor holders

3 superinvestors of the 157 tracked here hold Xenon Pharmaceuticals Inc (XENE) in their latest 13F filing, with $69.7M between them. Stanley Druckenmiller gives it the most weight: 0.33% of the reported portfolio. In their latest reported quarter, Paul Tudor Jones added.

Brandon Haley, Chuck Royce (founder) and Ron Baron sold out of it in their latest quarter.

Hold it now
3
of 157 tracked
Combined value
$69.7M
Bought / sold
1 / 3
last quarter

Key facts

Superinvestors holding it
3 of 157
Biggest holder
Paul Tudor Jones, $32.9M
Largest weight
Stanley Druckenmiller, 0.33%of their portfolio
Combined value
$69.7M
Bought last quarter
1
Sold last quarter
3

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding XENE, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Stanley DruckenmillerDuquesne Family Office0.33%$14.4M238.6KNo change0Q2 2026
2Paul Tudor JonesTudor Investment Corp0.14%$32.9M545.39K▲ Added 10%+49.81KQ2 2026
3Julian and Felix BakerBaker Bros. Advisors0.11%$22.3M370.21KNo change0Q2 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of XENE by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026920——02
Q2 202615731.15M$69.7M11
Q1 202615742.62M$152.5M30
Q4 20251571370.21K$16.6M00
Q3 202515722.35M$94.2M10
Q2 20251571370.21K$11.6M10
Q1 20251561347.41K$11.7M01
Q4 20241561993.68K$39M00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of XENE held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones·545.39K495.59K—————
Julian and Felix Baker·370.21K370.21K370.21K370.21K370.21K347.41K993.68K
Stanley Druckenmiller·238.6K238.6K—————
Brandon Haley·—1.52M—1.98M———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own XENE?

In their latest 13F filings: Stanley Druckenmiller (0.33% of the portfolio, $14.4M), Paul Tudor Jones (0.14% of the portfolio, $32.9M), Julian and Felix Baker (0.11% of the portfolio, $22.3M).

Who bought XENE last quarter?

Paul Tudor Jones (added 10%). “Last quarter” is each investor's latest reported quarter.

Who sold XENE last quarter?

Sold out entirely: Brandon Haley (was $88.3M), Chuck Royce (founder) (was $3.9M), Ron Baron (was $1.5M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Xenon Pharmaceuticals Inc (XENE)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/XENE/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to XENE by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.